As of 2026-03-31, the Intrinsic Value of Vor Biopharma Inc (VOR) is -294.98 USD. This VOR valuation is based on the model Peter Lynch Fair Value. With the current market price of 14.70 USD, the upside of Vor Biopharma Inc is -2,106.70%.
Based on its market price of 14.70 USD and our intrinsic valuation, Vor Biopharma Inc (VOR) is overvalued by 2,106.70%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -294.98 - -294.98 | -294.98 | -2,106.70% |
| P/E | (1,207.08) - (1,254.27) | (1,227.13) | -8447.9% |
| DDM - Stable | (632.21) - (2,756.59) | (1,694.40) | -11626.5% |
| DDM - Multi | (0.50) - (1.64) | (0.76) | -105.2% |
| Market Cap (mil) | 610.34 |
| Beta | 7.07 |
| Outstanding shares (mil) | 41.52 |
| Enterprise Value (mil) | 449.88 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.23% |
| Cost of Debt | 5.00% |
| WACC | 5.95% |